Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.00%6.82B | -10.84%6.37B | -17.00%1.47B | -11.16%1.67B | -8.58%1.6B | -6.44%1.62B | -7.71%7.14B | -10.48%1.78B | -5.78%1.89B | -7.81%1.75B |
| Cost of revenue | 5.89%5.03B | -17.06%4.75B | -21.30%1.18B | -21.57%1.16B | -15.13%1.19B | -9.41%1.22B | -3.37%5.72B | -6.10%1.5B | 0.07%1.48B | -4.65%1.4B |
| Gross profit | 10.26%1.79B | 14.22%1.62B | 5.93%297.09M | 26.71%514.87M | 17.21%415.95M | 4.15%394.72M | -21.85%1.42B | -28.29%280.46M | -22.32%406.34M | -18.47%354.86M |
| Operating expense | 5.54%1.6B | -7.85%1.52B | 1.80%388.01M | -11.18%395.24M | -11.71%350.32M | -9.43%385.69M | -1.13%1.65B | -1.64%381.13M | 0.10%445M | 1.04%396.77M |
| Staff costs | 1.85%522.83M | -0.89%513.32M | ---- | ---- | ---- | ---- | -6.61%517.95M | ---- | ---- | ---- |
| Selling and administrative expenses | ---- | ---- | ---- | -11.18%395.24M | -11.71%350.32M | -9.43%385.69M | ---- | ---- | 0.10%445M | 1.04%396.77M |
| -General and administrative expense | ---- | ---- | ---- | -11.18%395.24M | -11.71%350.32M | -9.43%385.69M | ---- | ---- | 0.10%445M | 1.04%396.77M |
| Research and development costs | -0.74%285.28M | -19.34%287.4M | ---- | ---- | ---- | ---- | 17.17%356.3M | ---- | ---- | ---- |
| Depreciation and amortization | 16.93%24.82M | -10.71%21.23M | ---- | ---- | ---- | ---- | -39.29%23.77M | ---- | ---- | ---- |
| -Depreciation | 16.93%24.82M | -10.71%21.23M | ---- | ---- | ---- | ---- | -39.29%23.77M | ---- | ---- | ---- |
| Other operating expenses | 10.49%770.45M | -7.11%697.32M | ---- | ---- | ---- | ---- | -2.46%750.72M | ---- | ---- | ---- |
| Operating profit | 79.64%185.68M | 145.32%103.36M | 9.69%-90.92M | 409.47%119.63M | 256.62%65.63M | 119.28%9.03M | -251.77%-228.08M | -2,903.43%-100.67M | -149.24%-38.66M | -198.41%-41.9M |
| Net non-operating interest income (expenses) | -27.07%-6.63M | -10.41%-5.22M | -14.47%-1.34M | -11.96%-1.33M | -10.99%-1.31M | -4.30%-1.24M | 10.92%-4.72M | -1.30%-1.17M | 4.04%-1.19M | 16.40%-1.18M |
| Non-operating interest income | 7,871.43%1.12M | -12.50%14K | 20.00%6K | 0.00%2K | -37.50%5K | 0.00%1K | -46.67%16K | -75.00%5K | 100.00%2K | 0.00%8K |
| Non-operating interest expense | 48.07%7.74M | 10.34%5.23M | 14.49%1.34M | 11.94%1.33M | 10.66%1.32M | 4.30%1.24M | -11.12%4.74M | 0.00%1.17M | -3.96%1.19M | -16.30%1.19M |
| Net investment income | 16.39%25.1M | 3.49%21.57M | 0.00%2.99M | 9.50%7.66M | 0.00%2.76M | 0.77%8.16M | 16.91%20.84M | 29.61%2.99M | 9.50%7M | 71.43%2.76M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -5,224.81%-105.57M | 2.06M | ||||||||
| Less:Other special charges | -6,664.61%-139.35M | ---2.06M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | --244.92M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 43.41%111.96M | -27.02%78.07M | -118.33%-7.44M | -49.25%21.21M | 182.51%40.46M | 131.91%23.84M | 297.91%106.98M | 569.00%40.59M | 504.92%41.79M | -2.47%14.32M |
| Income before tax | 5.35%210.55M | 290.36%199.85M | -62.45%-94.65M | 1,525.08%145.45M | 520.07%109.25M | 234.17%39.8M | -155.34%-104.98M | -1,389.75%-58.26M | -90.12%8.95M | -145.26%-26.01M |
| Income tax | 22.94%89.13M | 616.86%72.5M | -93.61%-25.39M | 336.72%47.16M | 856.42%36.04M | 311.35%14.69M | -123.07%-14.03M | -192.16%-13.11M | -64.13%10.8M | -124.52%-4.76M |
| Net income | -4.66%121.42M | 240.01%127.35M | -53.40%-69.26M | 5,418.40%98.28M | 444.65%73.22M | 210.55%25.11M | -170.56%-90.95M | -7,925.30%-45.15M | -103.06%-1.85M | -155.86%-21.24M |
| Net income continuous operations | -4.66%121.42M | 240.01%127.35M | -53.40%-69.26M | 5,415.52%98.28M | 444.64%73.22M | 210.55%25.11M | -170.56%-90.96M | -7,925.30%-45.15M | -103.06%-1.85M | -155.86%-21.24M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -4.66%121.42M | 240.01%127.35M | -53.40%-69.26M | 5,418.40%98.28M | 444.65%73.22M | 210.55%25.11M | -170.56%-90.95M | -7,925.30%-45.15M | -103.06%-1.85M | -155.86%-21.24M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -4.66%121.42M | 240.01%127.35M | -53.40%-69.26M | 5,418.40%98.28M | 444.65%73.22M | 210.55%25.11M | -170.56%-90.95M | -7,925.30%-45.15M | -103.06%-1.85M | -155.86%-21.24M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -3.79%16.01 | 240.07%16.64 | -53.22%-9.04 | 5,450.00%12.84 | 445.13%9.56 | 210.44%3.28 | -170.55%-11.88 | -7,475.00%-5.9 | -103.04%-0.24 | -155.85%-2.77 |
| Diluted earnings per share | -3.79%16.01 | 240.07%16.64 | -53.36%-9.0479 | 5,419.03%12.8394 | 444.52%9.56 | 210.44%3.28 | -170.55%-11.88 | -7,928.26%-5.9 | -103.06%-0.2414 | -155.95%-2.7749 |
| Dividend per share | 140.00%12 | 25.00%5 | 0.00%2 | 0 | 50.00%3 | 0 | -60.00%4 | -60.00%2 | 0 | -60.00%2 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |